ACAAI-AAN: The Next Steps in Peanut Allergy

Price: FREE for members and non-members

Session recorded on September 23, 2019
Speaker: Julie Wang, MD

Viewers can earn credit by completing the post test questions.


Learners will be able to accurately diagnose peanut allergy and provide evidence-based recommendations for management.  They will also be able to recognize the limitations of current diagnostic tests and knowledge gaps related to management, treatment and prevention of peanut allergy.

Accreditation

The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma and Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Practicing allergists/immunologists
Fellows-in-Training

Learning Objectives

1. Discuss current approaches to prevention, diagnosis, management and treatment of peanut allergy.
2. Identify unmet needs that require further research.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity.

Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.
Julie Wang, MD
Research grants: Aimmune, DBV, Regeneron
Consultant: DBV, ALK Abello

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
09/23/2019
Course expires: 
09/23/2020
Cost:
$0.00
Rating: 
0

Accreditation
The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma and Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
09/23/2019
Course expires: 
09/23/2020

Price

Cost:
$0.00
Please login or create an account to take this course.